Ridgefield, CT15 days ago
li>Works with the Medical Strategy Team Leader, the US TAs, global medical, Commercial operations, Go-To-Market (GTM), and CDMA leaders to identify and leverage synergies throughout the product lifecycle and actively provide input into clinical development early asset planning, Commercial strategies to ensure the success of launches and timely execution of prioritized evidence generation initiatives. Actively contributes at and represents the CDMA TA team in internal business planning workshops and relevant strategic planning governance regarding bronchiectasis products to ensure effective co-creation of appropriate, aligned, and integrated critical success factors, strategic imperatives, and their associated outcome measures (e.g., key performance indicators, metrics).